SERPINA1 and hyperinsulinemic hypoglycemia, familial, 4: Given the heterogeneity of liver disease in A1AT deficiency, it can be hypothesized that clinically significant liver damage occurs only in A1AT-deficient patients who also have some other defect in ER quality control and that these defects are heterogeneous among the affected population.